- Home
- JAMF vs CVAC Comparison
JAMF vs CVAC Comparison
Compare JAMF & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAMF
- CVAC
- Stock Information
- Founded
- JAMF 2002
- CVAC 2000
- Country
- JAMF United States
- CVAC Germany
- Employees
- JAMF N/A
- CVAC N/A
- Industry
- JAMF Computer Software: Prepackaged Software
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- JAMF Technology
- CVAC Health Care
- Exchange
- JAMF Nasdaq
- CVAC Nasdaq
- Market Cap
- JAMF 1.4B
- CVAC 1.2B
- IPO Year
- JAMF 2020
- CVAC 2020
- Fundamental
- Price
- JAMF $10.67
- CVAC $5.37
- Analyst Decision
- JAMF Buy
- CVAC Hold
- Analyst Count
- JAMF 11
- CVAC 3
- Target Price
- JAMF $16.27
- CVAC $6.83
- AVG Volume (30 Days)
- JAMF 1.4M
- CVAC 417.8K
- Earning Date
- JAMF 11-10-2025
- CVAC 11-11-2025
- Dividend Yield
- JAMF N/A
- CVAC N/A
- EPS Growth
- JAMF N/A
- CVAC N/A
- EPS
- JAMF N/A
- CVAC 1.01
- Revenue
- JAMF $666,382,000.00
- CVAC $599,540,810.00
- Revenue This Year
- JAMF $14.24
- CVAC N/A
- Revenue Next Year
- JAMF $9.60
- CVAC $23.83
- P/E Ratio
- JAMF N/A
- CVAC $5.33
- Revenue Growth
- JAMF 11.36
- CVAC 675.15
- 52 Week Low
- JAMF $7.09
- CVAC $2.37
- 52 Week High
- JAMF $18.00
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- JAMF 56.65
- CVAC 46.33
- Support Level
- JAMF $10.40
- CVAC $5.34
- Resistance Level
- JAMF $10.73
- CVAC $5.41
- Average True Range (ATR)
- JAMF 0.32
- CVAC 0.04
- MACD
- JAMF 0.01
- CVAC -0.00
- Stochastic Oscillator
- JAMF 92.49
- CVAC 26.32
About JAMF Jamf Holding Corp.
Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.